Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update.
Jonna S, Subramaniam DS.
Discov Med. 2019 Mar;27(148):167-170.
Update 2020: Management of Non-Small Cell Lung Cancer.
Alexander M, Kim SY, Cheng H.
Lung. 2020 Dec;198(6):897-907. doi: 10.1007/s00408-020-00407-5. Epub 2020 Nov 11.
The biology and management of non-small cell lung cancer.
Herbst RS, Morgensztern D, Boshoff C.
Nature. 2018 Jan 24;553(7689):446-454. doi: 10.1038/nature25183.
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology.
Riely GJ, Wood DE, Ettinger DS, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, DeCamp M, Desai AP, Dilling TJ, Dowell J, Durm GA, Gettinger S, Grotz TE, Gubens MA, Juloori A, Lackner RP, Lanuti M, Lin J, Loo BW, Lovly CM, Maldonado F, Massarelli E, Morgensztern D, Mullikin TC, Ng T, Owen D, Owen DH, Patel SP, Patil T, Polanco PM, Riess J, Shapiro TA, Singh AP, Stevenson J, Tam A, Tanvetyanon T, Yanagawa J, Yang SC, Yau E, Gregory KM, Hang L.
J Natl Compr Canc Netw. 2024 May;22(4):249-274. doi: 10.6004/jnccn.2204.0023.
Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives.
Imyanitov EN, Iyevleva AG, Levchenko EV.
Crit Rev Oncol Hematol. 2021 Jan;157:103194. doi: 10.1016/j.critrevonc.2020.103194. Epub 2020 Dec 11.
SMARCA4: Current status and future perspectives in non-small-cell lung cancer.
Tian Y, Xu L, Li X, Li H, Zhao M.
Cancer Lett. 2023 Feb 1;554:216022. doi: 10.1016/j.canlet.2022.216022. Epub 2022 Nov 28.
Abandoning the Notion of Non-Small Cell Lung Cancer.
Relli V, Trerotola M, Guerra E, Alberti S.
Trends Mol Med. 2019 Jul;25(7):585-594. doi: 10.1016/j.molmed.2019.04.012. Epub 2019 May 30.
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J, Escriu C, Peters S; ESMO Guidelines Committee.
Ann Oncol. 2017 Jul 1;28(suppl_4):iv1-iv21. doi: 10.1093/annonc/mdx222.
Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer.
Nagano T, Tachihara M, Nishimura Y.
Curr Cancer Drug Targets. 2019;19(8):595-630. doi: 10.2174/1568009619666181210114559.
The evolving role of radiotherapy in non-small cell lung cancer.
Brown S, Banfill K, Aznar MC, Whitehurst P, Faivre Finn C.
Br J Radiol. 2019 Dec;92(1104):20190524. doi: 10.1259/bjr.20190524. Epub 2019 Sep 19.
